Recent Research

Stephen K. Klasko, MD, MBA

Eight years after being named President of Thomas Jefferson University and CEO of Jefferson Health, Stephen K. Klasko, MD, MBA, will retire from his position, effective December 31, 2021.

woman in yellow shirt standing outside.

Advocating for vulnerable populations to improve the care experience and health outcomes. 


CAR-T cells are less sensitive than other types of immunotherapy in detecting and killing melanoma cells, a finding that could help improve immunotherapy sensitivity. 

Older couple using telehealth on a smartphone

Plans national Consensus Conference on Research in Telehealth

woman standing with exercise ball

Using sensory integration therapy tools can help patients and families live more successful and satisfying lives. 

Evan Laine with gavel at East Falls campus

History professor explores significance of conspiracy theories – and Senator Arlen Spector.

woman holding back in pain

Therapies that target aging cells early pave the way to easing back pain.


Pancreatic disease – even when the diagnosis isn’t cancer – can have severe impacts on a person’s well-being, according to new research. 


Combatting misconceptions and investigating the benefits of cannabis in treating disease. 

For news not listed on this page view the Jefferson News Archive